Melatonin - Clinical perspectives in prevention and therapy;Melatonin - Klinische Perspektiven in Pravention und Therapie

Therapeutische Umschau

Volumn 54, Issue 8, 1997, Pages 477-480

  Suhner, A ^a,b   Steffen, R ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

CANCER; CARDIOVASCULAR DISEASE; CONTRACEPTION; DRUG ACTIVITY; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG INDICATION; DRUG INFORMATION; HEADACHE; HUMAN; IMMUNOMODULATION; INSOMNIA; SHORT SURVEY; SIDE EFFECT; VERTIGO; ANIMAL; ARTICLE; CIRCADIAN RHYTHM; LONG TERM CARE; PHYSIOLOGY; PRIMARY PREVENTION; TRAVEL;

ANIMALS; CIRCADIAN RHYTHM; HUMANS; LONG-TERM CARE; MELATONIN; PRIMARY PREVENTION; TRAVEL;

EID: 0030859368     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Arendt J.: Melatonin, Clin. Endocrinol. 29, 205-229, 1988.
2. Aldhous M., Franey C., Wright J., Arendt J.: Plasma concentrations of melatonin in man following oral absorption of different preparations. Br. J. Clin. Pharmacol. 19, 517-521, 1985.
3. Di W.-L., Kadva A., Johnston A., Silmann R.: Variable bioavailability of oral melatonin. N. Engl. J. Med. 336, 1028-1029, 1997.
4. Maestroni G.J.M., Conti A., Pierpaoli W.: Role of the pineal gland in immunity: Melatonin antagonizes the immunosuppressive effect or acute stress via an opiateric mechanism. Immunology, 63, 465-469, 1988.
5. Cohen M., Lippman M., Chabner B.: Role of pineal gland in aetiology and treatment of breast cancer. Lancet, 2, 814-816, 1978.
6. Mühlgassner A.M.: Melatonin und Endometriumkarzinom, Test zum Überleben. Österr. Ärztezeitung 51(20), 25. 0kt., 34-35, 1996.
7. Brugger P., Marktl W., Herold M.: Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 345, 1408, 1995.
8. Pierpaoli W., Regelson W.: Pineal control of aging: Effect of melatonin and pineal grafting on aging mice. Proc. Natl. Acad. Sci. USA 91, 787-791, 1994.
9. Silman R.: Melatonin and the human gonadotropin-releasing hormone pulse generator: J. Endocrinol. 128, 7-11, 1991
10. Voordouw B. C., Euser R., Verdonk R.E. et al: Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J. Clin. Endocrinol. Metab. 74, 108-117, 1992.
11. Lewy A. J., Ahmed S., Jackson J. M. L., Sack R. L.: Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol. Int. 9, 380-392, 1992.
12. Arendt J., Aldhous M., English J, et al.: Some effects of jet-lag and their alleviation by melatonin. Ergonomics 30, 1379-1393, 1987.
13. Petrie K., Dawson A. G., Thompson L., Brook, R.: A double blind trial of melatonin as a treatment for jet lag in international cabin crew. Biological Psychiatry 33, 526-530, 1993.
14. Folkard S., Arendt J., Clark M.: Can melatonin improve shift worker's tolerance of the night shift? Some preliminary findings. Chronobiol. Int. 10, 315-320, 1993
15. Sack R. L., Lewy A. J., Blood M. L. et al.: Melatonin administration to blind people: phase advances and entrainment. J. Biol. Rhythms 6, 249-261, 1991.
16. Brunner D. P., Wirz-Justice A.: Chronobiologische Schlafstörungen und ihre Behandlungsmöglichkeiten. Therapeutische Umschau 50(10), 704-708, 1993.
17. Middleton B.A., Stone B.M., Arendt J.: Melatonin and fragmented sleep patterns. Lancet, 348, 551, 1996.